Radical Catheter Technologies’ 8F Neurovascular Catheter Receives US FDA 510(k) Clearance, Second for the Best-in-Class Ribbon Technology Platform
15 janv. 2025 09h00 HE
|
Radical Catheter Technologies
CAMPBELL, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Radical™ Catheter Technologies, a pioneering medical device company focused on advancing the next generation of endovascular access and delivery,...
Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers
14 janv. 2025 09h25 HE
|
22nd Century Group, Inc.
VLN Reduced Nicotine Content Cigarettes from 22nd Century Is the Only Authorized Combustible Solution to Support the FDA’s War on Smoking MOCKSVILLE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- 22nd...
FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
13 janv. 2025 08h30 HE
|
SeaStar Medical Holding Corporation
Study to be conducted under $3.6 million NIH grant DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing...
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes
13 janv. 2025 07h30 HE
|
22nd Century Group, Inc.
FDA Reduced Nicotine Content Proposal Indicated to Have Completed OMB Review as of January 3, 2025 FDA Spokesperson Indicates Policy Could Be Among Most Impactful Population-Level Actions in the...
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
13 janv. 2025 07h00 HE
|
CytoSorbents
CytoSorbents Strengthens Balance Sheet by $11.25M in Unrestricted Cash through Oversubscribed Shareholder Rights Offering and Satisfied Debt Covenant
Theratechnologies fait le point sur l’approvisionnement d’EGRIFTA SV(MD)
09 janv. 2025 17h05 HE
|
Theratechnologies
MONTRÉAL, 09 janv. 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée sur la mise au...
Theratechnologies Provides Update on EGRIFTA SV® Supply
09 janv. 2025 17h05 HE
|
Theratechnologies
MONTREAL, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
NurExone Biologic Secures Master Cell Bank
08 janv. 2025 16h12 HE
|
NurExone Biologic Inc
NurExone Biologic Secures Master Cell Bank - a Key Milestone for Therapeutic Exosome Production
California Wildfires and Worsening Outdoor Air Quality Drive Increased Demand for Air Purifiers, Says Kronos Advanced Technologies
08 janv. 2025 14h06 HE
|
Kronos Advanced Technologies Inc.
Los Angeles, CA , Jan. 08, 2025 (GLOBE NEWSWIRE) -- Los Angeles, CA – January 8, 2025 – KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), a leader in...
KRTL Holding Group Inc. Announces KRTL Biotech Inc. Acquires 55% Majority Stake in Nutrivance Global to Enhance API Distribution and Real-World Data Capabilities
08 janv. 2025 09h00 HE
|
KRTL Holding Group
Lakewood, CO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL) announces that its wholly owned subsidiary, KRTL Biotech Inc., has acquired a 55% majority equity stake in...